Age
stringclasses 73
values | Date of Data Entry
stringlengths 4
19
| Gender
stringclasses 3
values | Diagnosis
stringlengths 3
81
| Name of Drug
stringclasses 57
values | Dosage (gram)
stringclasses 28
values | Route
stringclasses 4
values | Frequency
stringclasses 6
values | Duration (days)
stringclasses 15
values | Indication
stringlengths 1
53
⌀ |
---|---|---|---|---|---|---|---|---|---|
70
|
19/12/2019 14:53:11
|
Male
|
septic shock, miliary tb, cerebral infarct, herpes encephalitis
|
meropenem
|
0.5
|
IV
|
BD
|
2
|
miliary tb
|
70
|
19/12/2019 14:54:47
|
Male
|
septic shock, miliary tb, cerebral infarct, herpes encephalitis
|
septrin
|
0.48
|
Oral
|
OD
|
1
|
miliary tb
|
60
|
19/12/2019 14:47:41
|
Female
|
chest infection, multinodular goiter, rt, hudronephrosis, thyrotoxicosis
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
2
|
multinodular goiter
|
60
|
19/12/2019 14:45:48
|
Female
|
chest infection, multinodular goiter, rt, hydronephrosis, thyrotoxicosis
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
5
|
multinodular goiter
|
65
|
19/12/2019 15:40:46
|
Male
|
multiple myeloma, acute ge
|
co-amoxiclav
|
0.6
|
IV
|
BD
|
2
|
multiple myeloma
|
65
|
19/12/2019 15:44:08
|
Male
|
multiple myeloma, acute ge
|
levofloxacin
|
0.5
|
Oral
|
OD
|
10
|
multiple myeloma
|
65
|
19/12/2019 15:46:01
|
Male
|
multiple myeloma, acute ge
|
levofloxacin
|
0.5
|
IV
|
OD
|
10
|
multiple myeloma
|
65
|
19/12/2019 15:47:57
|
Male
|
multiple myeloma, acute ge
|
cefoperazone
|
1
|
IV
|
BD
|
10
|
multiple myeloma
|
78
|
19/12/2019 14:09:00
|
Male
|
severe anaemia, multiple myeloma, CKD, chest infection
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
multiple myeloma
|
78
|
19/12/2019 14:10:25
|
Male
|
severe anaemia, multiple myeloma, CKD, chest infection
|
clarthromycin
|
0.5
|
Oral
|
BD
|
1
|
multiple myeloma
|
78
|
19/12/2019 14:11:59
|
Male
|
severe anaemia, multiple myeloma, CKD, chest infection
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
1
|
multiple myeloma
|
78
|
19/12/2019 14:13:30
|
Male
|
severe anaemia, multiple myeloma, CKD, chest infection
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
multiple myeloma
|
54
|
19/12/2019 14:45:52
|
Female
|
hydropneumothorax, empyema, type 2 dm, myoma uterus
|
metronidazole
|
0.75
|
IV
|
TDS
|
1
|
myoma uterus
|
54
|
19/12/2019 14:47:44
|
Female
|
hydropneumothorax, empyema, type 2 dm, myoma uterus
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
14
|
myoma uterus
|
70
|
19/12/2019 14:04:55
|
Female
|
neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
neutropenia
|
70
|
19/12/2019 14:05:42
|
Female
|
neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm
|
amikacin
|
0.5
|
IV
|
BD
|
8
|
neutropenia
|
70
|
19/12/2019 14:06:17
|
Female
|
neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm
|
ceftazidime
|
2
|
IV
|
TDS
|
2
|
neutropenia
|
78
|
19/12/2019 14:23:17
|
Female
|
anteroseptal mi, klebsiella pneumonia, hypertension, type 2 dm, old stroke
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
8
|
old stroke
|
87
|
19/12/2019 16:35:25
|
Female
|
pad(lt u.l), be amputation,/post op, akt
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
pad(lt u.l)
|
31
|
19/12/2019 14:50:02
|
Male
|
pancreatitis, chronic alcoholics
|
ceftriaxone
|
1
|
IV
|
BD
|
4
|
pancreatitis
|
40
|
19/12/2019 14:09:50
|
Male
|
pcp, septic shock
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
pcp
|
40
|
19/12/2019 14:10:26
|
Male
|
pcp, septic shock
|
septrin
|
0.96
|
Oral
|
TDS
|
1
|
pcp
|
31
|
19/12/2019 14:17:31
|
Female
|
PE in distal branches of left lung pul arteries
|
clarithromycin
|
0.5
|
Oral
|
BD
|
7
|
PE in distal branches of left lung pul arteries
|
31
|
19/12/2019 14:18:30
|
Female
|
PE in distal branches of left lung pul arteries
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
PE in distal branches of left lung pul arteries
|
31
|
19/12/2019 14:16:00
|
Female
|
pe in distal bronchi of left lung pulmonary arteries
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
10
|
pe in distal bronchi of left lung pulmonary arteries
|
17
|
19/12/2019 16:10:44
|
Male
|
anaphylaxis (?penicillin)
|
clindamycin
|
0.3
|
Oral
|
TDS
|
1
|
penicillin allergy(wound infection)
|
28
|
19/12/2019 13:54:08
|
Female
|
chikungunya, rash
|
ceftriaxone
|
1
|
IV
|
BD
|
5
|
penicillin induced drug reaction
|
56
|
19/12/2019 15:03:38
|
Male
|
alcoholic hepatitis, col, he, hypokalaemia
|
ceftriaxone
|
1
|
IV
|
BD
|
4
|
periodic hypokalaemic paralysis
|
58
|
19/12/2019 14:14:42
|
Male
|
copd, piles, cva
|
ceftazidime
|
1
|
IV
|
TDS
|
6
|
piles
|
35
|
19/12/2019 14:38:14
|
Male
|
pleural effusion
|
co-amoxiclav
|
0.625
|
IV
|
OD
|
1
|
pleural effusion
|
35
|
19/12/2019 14:39:24
|
Male
|
pleural effusion
|
septrin
|
0.96
|
Oral
|
OD
|
1
|
pleural effusion
|
71
|
19/12/2019 14:20:05
|
Male
|
rvi stage 2, polyerythremia
|
septrin
|
960
|
Oral
|
OD
|
1
|
polyerythremia
|
40
|
19/12/2019 16:20:07
|
Male
|
he, col, portal hypertension, hrs, koch's lung
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
portal hypertension
|
40
|
19/12/2019 16:21:01
|
Male
|
he, col, portal hypertension, hrs, koch's lung
|
rifampicin
|
0.55
|
Oral
|
BD
|
1
|
portal hypertension
|
37
|
19/12/2019 16:31:43
|
Male
|
massive ascites, col, portal hypertension
|
ceftriaxone
|
1
|
IV
|
BD
|
4
|
portal hypertension
|
37
|
19/12/2019 16:32:52
|
Male
|
massive ascites, col, portal hypertension
|
septrin
|
0.96
|
Oral
|
OD
|
1
|
portal hypertension
|
49
|
19/12/2019 14:39:20
|
Female
|
bppv, type2 DM, postural hypertension
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
postural hypertension
|
49
|
19/12/2019 14:40:19
|
Female
|
bppv, type2 DM, postural hypertension
|
cefixime
|
1
|
Oral
|
BD
|
5
|
postural hypertension
|
50
|
19/12/2019 14:40:27
|
Male
|
treated hcv, pott’s spine
|
cefixime
|
0.2
|
Oral
|
BD
|
5
|
pott’s spine
|
65
|
19/12/2019 16:22:50
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
co-amoxiclav
|
1
|
IV
|
TDS
|
1
|
pre-diabetes
|
65
|
19/12/2019 16:24:34
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
2
|
pre-diabetes
|
65
|
19/12/2019 16:25:18
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
clarithromycin
|
0.5
|
Oral
|
BD
|
4
|
pre-diabetes
|
65
|
19/12/2019 16:25:52
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
pre-diabetes
|
49
|
19/12/2019 15:09:08
|
Male
|
haematemesis, chronic alcoholic, he, acute gastric erosion
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
prevention of infection
|
71
|
19/12/2019 15:12:17
|
Female
|
dka, type 2 dm, ihd
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
prevention of infection
|
32
|
19/12/2019 15:18:14
|
Male
|
hepatitis, hypokalaemia, hcc, lichen amyloidosis
|
pentoxyfylline
|
0.4
|
Oral
|
TDS
|
1
|
prevention of infection
|
50
|
19/12/2019 15:32:06
|
Male
|
acute ge, pancytopenia
|
metronidazole
|
0.75
|
IV
|
TDS
|
4
|
prevention of infection
|
43
|
19/12/2019 15:00:19
|
Female
|
supine bite
|
amoxicillin+flucloxacillin
|
0.5
|
Oral
|
TDS
|
5
|
prevention of infection
|
35
|
19/12/2019 15:06:44
|
Female
|
green snake bite
|
amoxicillin+flucloxacillin
|
0.5
|
Oral
|
TDS
|
5
|
prevention of infection
|
21
|
19/12/2019 15:27:01
|
Male
|
lung abscess
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
4
|
prevention of infection
|
21
|
19/12/2019 15:27:57
|
Male
|
lung abscess
|
metronidazole
|
0.75
|
IV
|
TDS
|
9
|
prevention of infection
|
21
|
19/12/2019 15:28:54
|
Male
|
lung abscess
|
imipenem
|
0.5
|
IV
|
QID
|
7
|
prevention of infection
|
73
|
19/12/2019 15:15:27
|
Female
|
chest infection, copd
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
prevention of infection
|
73
|
19/12/2019 15:16:33
|
Female
|
chest infection, copd
|
clarithromycin
|
0.5
|
Oral
|
BD
|
5
|
prevention of infection
|
17
|
19/12/2019 15:18:11
|
Male
|
viral encephalitis, depressive d/o
|
ceftriaxone
|
1
|
IV
|
BD
|
7
|
prevention of infection
|
17
|
19/12/2019 15:19:19
|
Male
|
viral hepatitis, depressive d/o
|
ceftriaxone
|
1
|
IV
|
BD
|
5
|
prevention of infection
|
52
|
19/12/2019 15:14:02
|
Male
|
hmac nsaid induced piles gastritis
|
cefixime
|
0.2
|
Oral
|
BD
|
5
|
prevention of infection
|
15
|
19/12/2019 15:14:06
|
Male
|
avi
|
cefixime
|
0.2
|
Oral
|
BD
|
2
|
prevention of infection
|
56
|
19/12/2019 15:18:37
|
Male
|
rvi satge iv, rt-sided pleural effusion, 1st line art resistence, on anti-tb
|
streptomycin
|
0.75
|
IM
|
OD
|
7
|
prevention of infection
|
56
|
19/12/2019 15:20:23
|
Male
|
rvi satge iv, rt-sided pleural effusion, 1st line art resistence, on anti-tb
|
levofloxacin
|
0.5
|
Oral
|
OD
|
7
|
prevention of infection
|
56
|
19/12/2019 15:23:06
|
Male
|
rvi satge iv, rt-sided pleural effusion, 1st line art resistence, on anti-tb
|
septrin
|
0.96
|
Oral
|
OD
|
7
|
prevention of infection
|
42
|
19/12/2019 15:27:27
|
Male
|
stroke, newly diagnosis rvi, hbv infection
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
prevention of infection
|
23
|
19/12/2019 15:32:12
|
Female
|
acute hepatitis, clinical malaria
|
doxycyclin
|
0.1
|
Oral
|
BD
|
7
|
prevention of infection
|
49
|
19/12/2019 15:35:06
|
Female
|
pleural effusion, icm, ca breast
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
prevention of infection
|
55
|
19/12/2019 15:39:34
|
Female
|
chest infection, dm, ckd, traction retinal detachment
|
co-amoxiclav
|
0.6
|
IV
|
BD
|
7
|
prevention of infection
|
22
|
19/12/2019 15:04:18
|
Female
|
chikangunya
|
azithromycin
|
0.5
|
Oral
|
OD
|
5
|
fever
|
45
|
19/12/2019 15:21:36
|
Female
|
skin infection, staphylococcal infection, tb
|
levefloxacin
|
0.5
|
IV
|
OD
|
5
|
fever
|
32
|
19/12/2019 15:30:42
|
Male
|
prolonged fever ē, hypotension(leptospirosis)
|
ceftriaxone
|
1
|
IV
|
BD
|
4
|
fever
|
45
|
19/12/2019 15:19:24
|
Female
|
skin infection, staphylococcal infection, tb
|
amoxicillin+flucoxacillin
|
1
|
IV
|
QID
|
1
|
fever
|
45
|
19/12/2019 15:20:20
|
Female
|
skin infection, staphylococcal infection, tb
|
metronidazole
|
0.75
|
IV
|
TDS
|
11
|
fever
|
50
|
19/12/2019 16:27:17
|
Male
|
thyrotoxicosis, joint pain, puo
|
ceftriaxone
|
1
|
IV
|
BD
|
4
|
puo
|
18
|
19/12/2019 13:57:12
|
Male
|
pyexia of unknown origin
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
pyexia of unknown origin
|
45
|
19/12/2019 15:28:11
|
Female
|
recurrent uti, type 2 dm
|
meropenem
|
500
|
IV
|
TDS
|
4
|
uti
|
52
|
19/12/2019 14:37:18
|
Female
|
rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft
|
septrin
|
0.96
|
Oral
|
OD
|
1
|
renal impairment
|
52
|
19/12/2019 14:38:22
|
Female
|
rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft
|
coamoxiclav
|
0.6
|
IV
|
OD
|
5
|
renal impairment
|
52
|
19/12/2019 14:39:09
|
Female
|
rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft
|
co-amoxiclav
|
1.2
|
IV
|
BD
|
2
|
renal impairment
|
43
|
19/12/2019 14:56:32
|
Male
|
acute severe asthma
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
respiratory infection
|
32
|
19/12/2019 16:14:45
|
Female
|
general debility e excessive vomitting, uraemic gastritis, hcv aki ckd, retro(+)
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
2
|
retro(+)
|
32
|
19/12/2019 16:15:20
|
Female
|
general debility e excessive vomitting, uraemic gastritis, hcv aki ckd, retro(+)
|
co-amoxiclav
|
0.6
|
Oral
|
OD
|
2
|
retro(+)
|
32
|
19/12/2019 16:17:20
|
Female
|
general debility e excessive vomitting, uraemic gastritis, hcv aki ckd, retro(+)
|
septrin
|
0.96
|
Oral
|
OD
|
1
|
retro(+)
|
35
|
19/12/2019 15:19:59
|
Female
|
rheumatic heart disease with atrial flutter
|
pen v
|
0.25
|
Oral
|
QID
|
7
|
rheumatic fever
|
42
|
19/12/2019 14:59:14
|
Female
|
acute ge, rhd( severe ms mild mr) e af on warfrin
|
cifran
|
0.75
|
IV
|
BD
|
3
|
rheumatic heart disease
|
42
|
19/12/2019 15:04:50
|
Female
|
acute ge, rhd(severe ms mild mr) e af on warfrin
|
metronidazole
|
0.75
|
IV
|
TDS
|
3
|
rheumatic heart disease
|
42
|
19/12/2019 15:06:14
|
Female
|
acute ge, rhd(severe ms mild mr) e af on warfrin
|
pen v
|
0.25
|
Oral
|
BD
|
3
|
rheumatic heart disease
|
69
|
19/12/2019 14:04:40
|
Female
|
gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg
|
metronidazole
|
0.75
|
IV
|
TDS
|
5
|
right cerebral infarct
|
69
|
19/12/2019 14:08:30
|
Female
|
gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg
|
cefipime
|
1
|
IV
|
BD
|
1
|
right cerebral infarct
|
29
|
19/12/2019 14:51:40
|
Female
|
right lobe consolidation chest infection, thrombocytopenia
|
clarithromycin
|
0.5
|
Oral
|
BD
|
5
|
right lobe consolidation
|
29
|
19/12/2019 14:47:30
|
Female
|
right lower lobe consolidation chest infection, thrombocytopenia
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
3
|
right lower lobe consolidation
|
38
|
19/12/2019 14:50:17
|
Male
|
right sided hemiplegia, uncontrolled dm, chronic pancreatitis, chronix diarrhoea
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
right sided hemiplegia
|
60
|
19/12/2019 14:47:41
|
Female
|
chest infection, multinodular goiter, rt, hudronephrosis, thyrotoxicosis
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
2
|
rt
|
60
|
19/12/2019 14:45:48
|
Female
|
chest infection, multinodular goiter, rt, hydronephrosis, thyrotoxicosis
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
5
|
rt
|
31
|
19/12/2019 14:30:33
|
Female
|
rvi, stage4, art noise, hepatitis, bone marrow depression
|
cefipime
|
1
|
IV
|
BD
|
4
|
rvi
|
48
|
19/12/2019 15:37:12
|
Female
|
he, rvi with col
|
ceftriaxone
|
1
|
IV
|
OD
|
8
|
rvi
|
48
|
19/12/2019 15:40:22
|
Female
|
he, rvi with col
|
levofloxacin
|
0.25
|
IV
|
OD
|
3
|
rvi
|
48
|
19/12/2019 15:34:56
|
Female
|
he, rvi with col
|
ceftriaxone
|
1
|
IV
|
BD
|
8
|
rvi
|
48
|
19/12/2019 15:38:59
|
Female
|
he, rvi with col
|
levofloxacin
|
0.5
|
IV
|
OD
|
8
|
rvi
|
71
|
19/12/2019 14:20:05
|
Male
|
rvi stage 2, polyerythremia
|
septrin
|
960
|
Oral
|
OD
|
1
|
rvi
|
52
|
19/12/2019 14:37:18
|
Female
|
rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft
|
septrin
|
0.96
|
Oral
|
OD
|
1
|
rvi
|
52
|
19/12/2019 14:38:22
|
Female
|
rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft
|
coamoxiclav
|
0.6
|
IV
|
OD
|
5
|
rvi
|
52
|
19/12/2019 14:39:09
|
Female
|
rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft
|
co-amoxiclav
|
1.2
|
IV
|
BD
|
2
|
rvi
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.